These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 10716459

  • 1. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).
    Jørgensen B, Simonsen S, Endresen K, Forfang K, Vatne K, Hansen J, Webb J, Buller C, Goulet G, Erikssen J, Thaulow E.
    J Am Coll Cardiol; 2000 Mar 01; 35(3):592-9. PubMed ID: 10716459
    [Abstract] [Full Text] [Related]

  • 2. Results and clinical implications of the CAPARES trial.
    Thaulow E, Jorgensen B.
    Can J Cardiol; 2000 Jul 01; 16 Suppl D():8D-11D. PubMed ID: 10932030
    [Abstract] [Full Text] [Related]

  • 3. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
    Jørgensen B, Thaulow E, Coronary Angioplasty Amlodipine Restenosis Study.
    Am Heart J; 2003 Jun 01; 145(6):1030-5. PubMed ID: 12796759
    [Abstract] [Full Text] [Related]

  • 4. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
    Karsch KR, Preisack MB, Baildon R, Eschenfelder V, Foley D, Garcia EJ, Kaltenbach M, Meisner C, Selbmann HK, Serruys PW, Shiu MF, Sujatta M, Bonan R.
    J Am Coll Cardiol; 1996 Nov 15; 28(6):1437-43. PubMed ID: 8917255
    [Abstract] [Full Text] [Related]

  • 5. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW, Foley DP, Jackson G, Bonnier H, Macaya C, Vrolix M, Branzi A, Shepherd J, Suryapranata H, de Feyter PJ, Melkert R, van Es GA, Pfister PJ.
    Eur Heart J; 1999 Jan 15; 20(1):58-69. PubMed ID: 10075142
    [Abstract] [Full Text] [Related]

  • 6. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP, Bonnier H, Jackson G, Macaya C, Shepherd J, Vrolix M, Serruys PW.
    Am J Cardiol; 1994 May 26; 73(14):50D-61D. PubMed ID: 8198025
    [Abstract] [Full Text] [Related]

  • 7. A pharmacoeconomic evaluation of results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) in Norway and Canada.
    Thaulow E, Jorgensen B, Doyle JJ, Casciano R, Casciano J, Kopp Z, Arikian S, Kim R.
    Int J Cardiol; 2002 Jul 26; 84(1):23-30; discussion 30-2. PubMed ID: 12104059
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial.
    Serruys PW, Klein W, Tijssen JP, Rutsch W, Heyndrickx GR, Emanuelsson H, Ball SG, Decoster O, Schroeder E, Liberman H.
    Circulation; 1993 Oct 26; 88(4 Pt 1):1588-601. PubMed ID: 8403306
    [Abstract] [Full Text] [Related]

  • 9. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH, Spriggins D, Davies SW, Syndercombe Court YD, Timmins J, Timmis AD, Rothman MT, Layton C, Balcon R.
    Br Heart J; 1994 Jan 26; 71(1):7-15. PubMed ID: 8297699
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven.
    Dens JA, Desmet WJ, Coussement P, De Scheerder IK, Kostopoulos K, Kerdsinchai P, Supanantaroek C, Piessens JH.
    Am J Cardiol; 2001 Jan 01; 87(1):28-33. PubMed ID: 11137829
    [Abstract] [Full Text] [Related]

  • 11. [Low molecular weight heparin, reviparin, after PTCA: results of a randomized double-blind, standard heparin and placebo controlled multicenter study (REDUCE Study].
    Preisack MB, Baildon R, Eschenfelder V, Foley D, Garcia E, Kaltenbach M, Meisner C, Selbmann HK, Serruys PW, Shiu MF, Sujatta M, Bonan R, Karsch KR.
    Z Kardiol; 1997 Aug 01; 86(8):581-91. PubMed ID: 9417748
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic effects of calcium channel blockers on restenosis.
    Thaulow E.
    J Cardiovasc Pharmacol; 1999 Aug 01; 33 Suppl 2():S12-6. PubMed ID: 10071258
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.
    Bestehorn HP, Neumann FJ, Büttner HJ, Betz P, Stürzenhofecker P, von Hodenberg E, Verdun A, Levai L, Monassier JP, Roskamm H.
    J Am Coll Cardiol; 2004 Jun 16; 43(12):2160-5. PubMed ID: 15193674
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A, Rodríguez Alemparte M, Fernández Pereira C, Sampaolesi A, da Rocha Loures Bueno R, Vigo F, Obregón A, Palacios IF, LASMAL investigators.
    Am J Med; 2005 Jul 16; 118(7):743-51. PubMed ID: 15989908
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty.
    Desmet W, Vrolix M, De Scheerder I, Van Lierde J, Willems JL, Piessens J.
    Circulation; 1994 Jan 16; 89(1):385-92. PubMed ID: 8281674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.